VitalGo, Inc. v. Kreg Therapeutics, Inc.

CourtDistrict Court, N.D. Illinois
DecidedDecember 21, 2017
Docket1:16-cv-05577
StatusUnknown

This text of VitalGo, Inc. v. Kreg Therapeutics, Inc. (VitalGo, Inc. v. Kreg Therapeutics, Inc.) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
VitalGo, Inc. v. Kreg Therapeutics, Inc., (N.D. Ill. 2017).

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF ILLINOIS EASTERN DIVISION

VITALGO, Inc. and VITALGO SYSTEMS LTD., ) ) Plaintiffs, ) ) Case No. 16-cv-5577 v. ) ) Judge Robert M. Dow, Jr. KREG THERAPEUTICS, INC. and ) CRAIG POULOS, ) ) Defendants. )

MEMORANDUM OPINION AND ORDER

Plaintiffs VitalGo, Inc. (“VitalGo”) and VitalGo Systems Ltd. (“Plaintiffs”) bring this action against Defendants Kreg Therapeutics, Inc. (“Kreg”) and Craig Poulos (“Defendants”) alleging copyright and trademark infringement and unfair competition under federal and state law. Currently before the Court is Defendants’ combined motion [49] to strike portions of Plaintiffs’ First Amended Complaint and to dismiss all claims in the First Amended Complaint with prejudice and Defendants’ motion [55] to stay discovery. For the reasons stated below, Defendants’ motion [49] is granted and part and denied in part. The Court grants Defendants’ motion to strike in part: paragraphs 28–47, 50–53, 55, 64, 77–79, 84–87, 89–91, and 108–09, as well as portions of paragraphs 25 and 113 (25(1)–(10) and 113(1)–(10)), are stricken from the First Amended Complaint as they relate solely to the claims this Court has previously dismissed. Furthermore, the Court grants Defendants’ motion to dismiss Count II, Count III, Count V, Count VI, and Count VII, and denies Defendants’ motion to dismiss Count I and Count IV. Plaintiffs will be given one final attempt to replead Counts II, III, V, VI, and VII on or before January 22, 2018. Defendants’ motion [55] to stay discovery pending the resolution of its motion to strike and to dismiss is denied as moot. This case is set for further status on January 30, 2018 at 10:00 a.m. to discuss a discovery plan.1 Counsel are directed to confer and submit an updated joint status report no later than January 26, 2018. I. Background The background of this case, and of the more extensive litigation in which VitalGo and Kreg have been engaged before this Court, is set forth in the Court’s previous opinion in this

case, knowledge of which is assumed here. [See 41 at 1–7.] Briefly summarized, the parties entered into an agreement pursuant to which Kreg was granted the exclusive right to distribute Plaintiffs’ Total Lift Bed product in certain regions of the country. In 2011, VitalGo terminated the parties’ agreement, and Kreg thereafter filed suit (the “2011 Lawsuit”) against VitalGo for breach of that agreement. VitalGo counterclaimed that Kreg had violated the parties’ agreement by both making unauthorized alterations to the Total Lift Bed without VitalGo’s prior written approval and by failing to obtain VitalGo’s approval of all advertisements and promotional materials Kreg used to promote and sell Total Lift Beds.2 In May 2016, Plaintiffs filed the instant lawsuit, bringing claims against Defendants for

copyright infringement in violation of 17 U.S.C. § 501 (Count I); unfair competition and false designation of origin pursuant to Section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a)(1)(A) (Count II); unfair competition and false advertisement pursuant to Section 43(a) of the Lanham Act, 15 U.S.C. § 1125(a)(1)(B) (Count III); common law trademark infringement (Count IV);

1 In their motion [55] to stay discovery, Defendants have complained about the scope of the discovery requests that Plaintiffs served on them in May 2017. In light of the Court’s decision, Plaintiffs should retailor their requests to be consistent with the claims that are allowed to go forward. To the extent that Plaintiffs are successful in the future in meeting the Rule 9(b) particularity standard for the claims that are being dismissed here, Plaintiffs may expand the scope of discovery at the appropriate time.

2 The 2011 Lawsuit has concluded proceedings before the district court and is currently on appeal. After a bench trial, the Court concluded that Kreg was entitled to $642,610 in damages plus $364,593 in prejudgment interest, for a total award of $1,007,203. See Kreg Therapeutics, Inc. v. Vitalgo, Inc., Docket Entry 250, No. 11-cv-6771 (N.D. Ill.) (Memorandum Opinion and Order). common law unfair competition (Count V); violation of the Illinois Uniform Deceptive Trade Practices Act (IUDTPA), 815 Ill. Comp. Stat. 510/1 et seq. (Count VI); and violation of the Illinois Consumer Fraud and Deceptive Business Practices Act (ICFA), 815 Ill. Comp. Stat. 505/1 et seq. (Count VII). [1 ¶ 2.] According to the original complaint, Plaintiffs began using VitalGo and Total Lift Bed marks in the United States in 2008, Plaintiffs began showing the

Total Lift Bed in advertising and marketing materials in approximately 2008, and Plaintiffs have filed copyright applications for a brochure and for two digital renderings of the Total Lift Bed. [1 ¶¶ 14, 18.] Plaintiffs alleged that (1) Defendants marketed Plaintiffs’ Total Lift Bed as an “Exclusive Kreg Product” or as a “Kreg Bed” and used Plaintiffs’ Copyrighted Works in doing so since October 2011; (2) Defendants made modifications to Plaintiffs’ Total Lift Beds but continued to advertise them as Total Lift Beds in 2010 or 2011; and (3) Defendants developed the Kreg Catalyst Bed in 2014 to compete with the Total Lift Bed and, until March 2016, they promoted the Catalyst Bed using the Total Lift Bed mark and Plaintiffs’ Copyrighted Works. [41 at 7.]

Defendants moved to dismiss [18] Plaintiffs’ complaint in July 2016. To support their motion, Defendants argued that (1) Plaintiffs were judicially estopped from asserting their claims; (2) Plaintiffs’ claims could not be alleged in an independent lawsuit because they constituted impermissible claim splitting; (3) no factual allegations demonstrated Defendant Poulos’s personal liability; (4) the doctrine of laches barred Plaintiffs’ Lanham Act claims; (5) Plaintiffs did not allege actual consumer reliance on Defendants’ alleged misleading advertisements as necessary to support its Lanham Act claims; and (6) Plaintiffs could not seek attorneys’ fees under the Copyright Act. On March 29, 2017, the Court granted in part and denied in part Defendants’ motion. [See 41.] The Court held that the doctrine of claim splitting precluded Plaintiffs from bringing claims against Defendants relating to Defendants’ modifications to the Total Lift Bed and to Defendants’ allegedly infringing marketing and promotional materials for the Total Lift Bed because those claims were based on the same set of operative facts underlying VitalGo’s counterclaim in the 2011 Lawsuit. [41 at 9–18.] The Court also held that Plaintiffs could proceed with their claims to the extent these claims are based on

Defendants’ alleged marketing of their Catalyst Bed using Plaintiffs’ intellectual property because the underlying facts on which these allegations are based are separate and distinct from those underlying Plaintiff VitalGo’s counterclaims in the 2011 Lawsuit. [41 at 18–19.] The Court also dismissed Plaintiffs’ claims for attorneys’ fees pursuant to § 505 of the Copyright Act. [41 at 27.] Plaintiffs then filed their First Amended Complaint on May 3, 2017. [See 43.] Defendants responded on May 31, 2017 by filing the instant motion [49] to strike various allegations from the First Amended Complaint concerning the Total Lift Bed pursuant to Federal Rule of Civil Procedure (“Rule”) 12(f) and to dismiss the remaining claims in the First Amended

Complaint pursuant to Rule 12(b)(6). II. Defendants’ Rule 12(f) Motion to Strike A.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Zedner v. United States
547 U.S. 489 (Supreme Court, 2006)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Atkins v. City of Chicago
631 F.3d 823 (Seventh Circuit, 2011)
Melvin E. Levinson v. United States
969 F.2d 260 (Seventh Circuit, 1992)
Ennenga v. Starns
677 F.3d 766 (Seventh Circuit, 2012)
Robert H. Tice v. American Airlines, Inc.
373 F.3d 851 (Seventh Circuit, 2004)
James A. Knight v. Bank of America
695 F.3d 714 (Seventh Circuit, 2012)
Tamayo v. Blagojevich
526 F.3d 1074 (Seventh Circuit, 2008)
Killingsworth v. HSBC Bank Nevada, N.A.
507 F.3d 614 (Seventh Circuit, 2007)
Morningware, Inc. v. Hearthware Home Products, Inc.
673 F. Supp. 2d 630 (N.D. Illinois, 2009)
Cumis Insurance Society, Inc. v. Peters
983 F. Supp. 787 (N.D. Illinois, 1997)
Bob Creeden & Associates, Ltd. v. Infosoft, Inc.
326 F. Supp. 2d 876 (N.D. Illinois, 2004)

Cite This Page — Counsel Stack

Bluebook (online)
VitalGo, Inc. v. Kreg Therapeutics, Inc., Counsel Stack Legal Research, https://law.counselstack.com/opinion/vitalgo-inc-v-kreg-therapeutics-inc-ilnd-2017.